These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 12937086

  • 1. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M.
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [Abstract] [Full Text] [Related]

  • 2. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M.
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [Abstract] [Full Text] [Related]

  • 3. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mesaros S, Rocca M, Sormani M, Valsasina P, Markowitz C, De Stefano N, Montalban X, Barkhof F, Ranjeva J, Sailer M, Kappos L, Comi G, Filippi M.
    Mult Scler; 2010 Mar; 16(3):325-31. PubMed ID: 20086023
    [Abstract] [Full Text] [Related]

  • 4. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [Abstract] [Full Text] [Related]

  • 5. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 6. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL.
    J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
    [Abstract] [Full Text] [Related]

  • 7. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.
    Rovaris M, Judica E, Gallo A, Benedetti B, Sormani MP, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M.
    Brain; 2006 Oct; 129(Pt 10):2628-34. PubMed ID: 16921179
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 9. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C, Rovaris M, Iannucci G, Valsasina P, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Comi G, Filippi M.
    Arch Neurol; 2005 Apr 18; 62(4):578-84. PubMed ID: 15824256
    [Abstract] [Full Text] [Related]

  • 10. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 18; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 11. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP.
    Brain; 2006 Aug 18; 129(Pt 8):2008-16. PubMed ID: 16815879
    [Abstract] [Full Text] [Related]

  • 12. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.
    Rovaris M, Gallo A, Valsasina P, Benedetti B, Caputo D, Ghezzi A, Montanari E, Sormani MP, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M.
    Neuroimage; 2005 Feb 15; 24(4):1139-46. PubMed ID: 15670691
    [Abstract] [Full Text] [Related]

  • 13. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
    Río J, Rovira A, Tintoré M, Huerga E, Nos C, Tellez N, Tur C, Comabella M, Montalban X.
    Mult Scler; 2008 May 15; 14(4):479-84. PubMed ID: 18562504
    [Abstract] [Full Text] [Related]

  • 14. Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study.
    Rovaris M, Judica E, Ceccarelli A, Ghezzi A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2008 Jul 15; 14(6):853-6. PubMed ID: 18611991
    [Abstract] [Full Text] [Related]

  • 15. Thalamic damage and long-term progression of disability in multiple sclerosis.
    Rocca MA, Mesaros S, Pagani E, Sormani MP, Comi G, Filippi M.
    Radiology; 2010 Nov 15; 257(2):463-9. PubMed ID: 20724544
    [Abstract] [Full Text] [Related]

  • 16. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Rudick RA, Lee JC, Simon J, Fisher E.
    Ann Neurol; 2006 Aug 15; 60(2):236-42. PubMed ID: 16786526
    [Abstract] [Full Text] [Related]

  • 17. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
    Minneboo A, Uitdehaag BM, Jongen P, Vrenken H, Knol Dl, van Walderveen MA, Polman CH, Castelijns JA, Barkhof F.
    Mult Scler; 2009 May 15; 15(5):632-7. PubMed ID: 19389751
    [Abstract] [Full Text] [Related]

  • 18. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M.
    J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621
    [Abstract] [Full Text] [Related]

  • 19. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S, Enzinger C, Ropele S, Wallner M, Fazekas F.
    Mult Scler; 2008 Mar 30; 14(2):205-11. PubMed ID: 17986507
    [Abstract] [Full Text] [Related]

  • 20. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.
    Ann Neurol; 2010 Mar 30; 67(3):376-83. PubMed ID: 20373349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.